| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 9.80e-05 | 38 | 8 | 2 | GO:0000146 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.43e-04 | 279 | 8 | 3 | GO:0005096 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 8.29e-04 | 507 | 8 | 3 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 8.29e-04 | 507 | 8 | 3 | GO:0060589 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.47e-04 | 118 | 8 | 2 | GO:0003774 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.44e-03 | 614 | 8 | 3 | GO:0140657 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.75e-03 | 656 | 8 | 3 | GO:0008047 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 2.82e-03 | 775 | 8 | 3 | GO:0017111 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.44e-03 | 227 | 8 | 2 | GO:0051015 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 3.53e-03 | 839 | 8 | 3 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 3.54e-03 | 840 | 8 | 3 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.54e-03 | 840 | 8 | 3 | GO:0016818 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 1.04e-02 | 1233 | 8 | 3 | GO:0140677 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.25e-02 | 441 | 8 | 2 | GO:0016887 | |
| GeneOntologyMolecularFunction | actin binding | 1.46e-02 | 479 | 8 | 2 | GO:0003779 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 1.53e-02 | 1418 | 8 | 3 | GO:0030234 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | 8.76e-05 | 244 | 8 | 3 | GO:0043547 | |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 2.24e-04 | 335 | 8 | 3 | GO:0043087 | |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | 7.20e-04 | 499 | 8 | 3 | GO:0051345 | |
| GeneOntologyCellularComponent | myosin complex | 2.17e-04 | 59 | 8 | 2 | GO:0016459 | |
| GeneOntologyCellularComponent | actin filament | 1.32e-03 | 146 | 8 | 2 | GO:0005884 | |
| GeneOntologyCellularComponent | cell cortex | 8.20e-03 | 371 | 8 | 2 | GO:0005938 | |
| Domain | RA | 5.57e-05 | 31 | 7 | 2 | SM00314 | |
| Domain | RA | 7.54e-05 | 36 | 7 | 2 | PF00788 | |
| Domain | RA | 7.97e-05 | 37 | 7 | 2 | PS50200 | |
| Domain | MYOSIN_MOTOR | 8.41e-05 | 38 | 7 | 2 | PS51456 | |
| Domain | MYSc | 8.41e-05 | 38 | 7 | 2 | SM00242 | |
| Domain | Myosin_head | 8.41e-05 | 38 | 7 | 2 | PF00063 | |
| Domain | Myosin_head_motor_dom | 8.41e-05 | 38 | 7 | 2 | IPR001609 | |
| Domain | RA_dom | 9.33e-05 | 40 | 7 | 2 | IPR000159 | |
| Domain | RhoGAP | 2.25e-04 | 62 | 7 | 2 | SM00324 | |
| Domain | RhoGAP | 2.33e-04 | 63 | 7 | 2 | PF00620 | |
| Domain | ZF_DAG_PE_2 | 2.40e-04 | 64 | 7 | 2 | PS50081 | |
| Domain | ZF_DAG_PE_1 | 2.40e-04 | 64 | 7 | 2 | PS00479 | |
| Domain | - | 2.40e-04 | 64 | 7 | 2 | 1.10.555.10 | |
| Domain | RHOGAP | 2.40e-04 | 64 | 7 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 2.40e-04 | 64 | 7 | 2 | IPR000198 | |
| Domain | C1 | 2.48e-04 | 65 | 7 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 2.55e-04 | 66 | 7 | 2 | IPR002219 | |
| Domain | IQ | 2.96e-04 | 71 | 7 | 2 | PF00612 | |
| Domain | IQ | 3.85e-04 | 81 | 7 | 2 | SM00015 | |
| Domain | Rho_GTPase_activation_prot | 4.54e-04 | 88 | 7 | 2 | IPR008936 | |
| Domain | IQ_motif_EF-hand-BS | 4.75e-04 | 90 | 7 | 2 | IPR000048 | |
| Domain | IQ | 5.07e-04 | 93 | 7 | 2 | PS50096 | |
| Domain | Ubiquitin-rel_dom | 1.96e-03 | 184 | 7 | 2 | IPR029071 | |
| Domain | P-loop_NTPase | 2.85e-03 | 848 | 7 | 3 | IPR027417 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.34e-04 | 69 | 5 | 2 | MM15596 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.41e-04 | 70 | 5 | 2 | M41806 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 9.88e-04 | 142 | 5 | 2 | MM15576 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.09e-03 | 149 | 5 | 2 | M41805 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 9.09e-03 | 439 | 5 | 2 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 9.54e-03 | 450 | 5 | 2 | M27078 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.93e-02 | 649 | 5 | 2 | MM15690 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 32451867 | ||
| Pubmed | BIG1 is a binding partner of myosin IXb and regulates its Rho-GTPase activating protein activity. | 3.57e-07 | 4 | 9 | 2 | 15644318 | |
| Pubmed | 1.25e-06 | 7 | 9 | 2 | 11212352 | ||
| Pubmed | 5.41e-06 | 14 | 9 | 2 | 8022818 | ||
| Pubmed | 6.67e-05 | 48 | 9 | 2 | 8884266 | ||
| Pubmed | 1.49e-04 | 430 | 9 | 3 | 32581705 | ||
| Interaction | DQX1 interactions | 2.88e-05 | 21 | 8 | 2 | int:DQX1 | |
| Interaction | TMOD4 interactions | 5.57e-05 | 29 | 8 | 2 | int:TMOD4 | |
| Interaction | DKK3 interactions | 3.77e-04 | 75 | 8 | 2 | int:DKK3 | |
| Interaction | BPNT1 interactions | 6.17e-04 | 96 | 8 | 2 | int:BPNT1 | |
| Interaction | SKAP1 interactions | 6.96e-04 | 102 | 8 | 2 | int:SKAP1 | |
| Interaction | EMILIN1 interactions | 7.10e-04 | 103 | 8 | 2 | int:EMILIN1 | |
| Interaction | MYL6B interactions | 7.80e-04 | 108 | 8 | 2 | int:MYL6B | |
| Interaction | TRIM52 interactions | 1.18e-03 | 133 | 8 | 2 | int:TRIM52 | |
| GeneFamily | Myosins, class IX | 6.12e-08 | 2 | 5 | 2 | 1103 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_500 | 4.02e-05 | 26 | 8 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_500 | 5.37e-05 | 30 | 8 | 2 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.31e-04 | 74 | 8 | 2 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.58e-04 | 77 | 8 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_1000 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 123 | 9 | 2 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-04 | 147 | 9 | 2 | 743767abdb3b5ecad870b617f515b037ce280818 | |
| ToppCell | droplet-Liver-Npc-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-04 | 155 | 9 | 2 | 5d600e159738231d0607ea1a1ebd8510fc241b36 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 4.29e-04 | 157 | 9 | 2 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-04 | 158 | 9 | 2 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-04 | 158 | 9 | 2 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.40e-04 | 159 | 9 | 2 | a5509f0604ef0caef5ed1af83dd89c86686c73cc | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.73e-04 | 165 | 9 | 2 | 5f606959a060b1ae241217889560c6761ac73bbb | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 171 | 9 | 2 | 8719a18c9e6b6f5d8ec4e937c2bda1e36441c9ec | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 171 | 9 | 2 | f4cdd7862c8fe99ee765a2f3ed375b584f4976c5 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promonocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.32e-04 | 175 | 9 | 2 | 654299df246debe0a5b12f0d9568eb828bb94bb9 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.63e-04 | 180 | 9 | 2 | 40d4838a0ccb10d5e49266bc8a0037d27b75ccc2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-04 | 180 | 9 | 2 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-04 | 183 | 9 | 2 | f079179f2984def91ddf0b33d7949d5ecdbd380d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-04 | 183 | 9 | 2 | 49e8ee16e4f677f9f649e2a2faf1b9b16c5a27e7 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.07e-04 | 187 | 9 | 2 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 6.26e-04 | 190 | 9 | 2 | 85cf147f2baf2e575073b4edab57c7809475268a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.33e-04 | 191 | 9 | 2 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.33e-04 | 191 | 9 | 2 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | NS-moderate-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.39e-04 | 192 | 9 | 2 | 905217dcfc843d3469e9e71bd33707863b14cc82 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.39e-04 | 192 | 9 | 2 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-04 | 195 | 9 | 2 | d53585715c7f5827c4f5a6db11cb31857ee9d4f0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.66e-04 | 196 | 9 | 2 | de70cc301a8cbaedb0a5ea4a6442dcdaa477822d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.80e-04 | 198 | 9 | 2 | a5f5c0b42ae43ba48a7e4f06c4ad179b2244d941 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_Exhausted-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.80e-04 | 198 | 9 | 2 | bb99db3e04d547248ea66953c2f8dd55c530461c | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-04 | 199 | 9 | 2 | 598937913fe1f12d741fa49e23ae195a7be5cbe3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.87e-04 | 199 | 9 | 2 | 3f4907fa6d81c5691c19e6798145e9f9eccdfd20 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 6.87e-04 | 199 | 9 | 2 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Biopsy_IPF-Immune-Proliferating_T_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 6.93e-04 | 200 | 9 | 2 | c43d1a83b2a8ad060f3d80c9438da8b7a5e307fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.93e-04 | 200 | 9 | 2 | 562309f9ca4a73cea5ed1d85b516891545f3ae5f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.93e-04 | 200 | 9 | 2 | e269a61858ac610e914b684d9a3c084e9600fb1c | |
| ToppCell | COVID_vent|World / Disease condition, Lineage, Cell class and subclass | 6.93e-04 | 200 | 9 | 2 | 1d88e5cc4534073f27a7562e1c4b884bd67f09d9 | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A | 3.41e-05 | 196 | 8 | 3 | 1912_UP | |
| Drug | formycin triphosphate | 1.37e-04 | 51 | 8 | 2 | CID000122274 | |
| Drug | purealin | 1.77e-04 | 58 | 8 | 2 | CID006419303 | |
| Drug | S-(-)-Etomoxir | 5.26e-04 | 100 | 8 | 2 | CID000060765 | |
| Drug | blebbistatin | 7.06e-04 | 116 | 8 | 2 | CID003476986 | |
| Drug | B0683 | 7.18e-04 | 117 | 8 | 2 | CID006398969 | |
| Drug | clenbuterol | 1.06e-03 | 142 | 8 | 2 | CID000002783 | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 3518_DN | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.84e-03 | 188 | 8 | 2 | 3325_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | 1.88e-03 | 190 | 8 | 2 | 5786_UP | |
| Drug | Imipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 5997_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.90e-03 | 191 | 8 | 2 | 6022_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 5596_DN | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 4144_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 5990_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.94e-03 | 193 | 8 | 2 | 997_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 6956_DN | |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; HL60; HG-U133A | 1.94e-03 | 193 | 8 | 2 | 1749_DN | |
| Drug | LY294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 5965_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 3708_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 3969_DN | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 3303_DN | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 6575_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 2295_DN | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 4721_DN | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 2784_DN | |
| Drug | Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 2861_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 7362_DN | |
| Drug | Moroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 1527_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 1532_DN | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 7239_DN | |
| Drug | DAPH; Down 200; 10uM; PC3; HG-U133A | 1.98e-03 | 195 | 8 | 2 | 578_DN | |
| Drug | Perhexiline maleate [6724-53-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 7441_DN | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; PC3; HG-U133A | 1.98e-03 | 195 | 8 | 2 | 1911_UP | |
| Drug | Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 3580_DN | |
| Drug | Indomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5468_UP | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 6828_DN | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5424_DN | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5825_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5447_DN | |
| Drug | LY294002; Down 200; 10uM; MCF7; HG-U133A | 2.00e-03 | 196 | 8 | 2 | 328_DN | |
| Drug | Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2784_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7377_DN | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 6305_UP | |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; HL60; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2458_UP | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HG-U133A | 2.00e-03 | 196 | 8 | 2 | 1913_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4000_UP | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7222_DN | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2862_UP | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; HL60; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3032_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3271_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5322_UP | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4372_UP | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4840_DN | |
| Drug | Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7024_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2229_DN | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 7182_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 4420_UP | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5386_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.00e-03 | 196 | 8 | 2 | 1054_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HG-U133A | 2.00e-03 | 196 | 8 | 2 | 1904_UP | |
| Drug | Racecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 2774_UP | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 5293_DN | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6674_UP | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6106_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3573_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7341_DN | |
| Drug | 0198306-0000 [212631-61-3]; Up 200; 10uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7069_UP | |
| Drug | Fipexide hydrochloride [34161-23-4]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3176_DN | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6350_UP | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7019_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; HL60; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1402_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5332_DN | |
| Drug | Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6274_UP | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4976_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5765_UP | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 203_UP | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5493_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6787_DN | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1503_UP | |
| Drug | Benserazide hydrochloride [14919-77-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6482_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6449_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7273_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4764_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2766_UP | |
| Drug | Cyclopenthiazide [742-20-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7325_DN | |
| Drug | LY294002; Down 200; 10uM; SKMEL5; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 501_DN | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 2799_DN | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; PC3; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7266_DN | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7328_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; PC3; HG-U133A | 2.04e-03 | 198 | 8 | 2 | 1906_UP | |
| Disease | Celiac Disease | 6.91e-05 | 47 | 8 | 2 | C0007570 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSPHANKKKHLKKKS | 241 | Q8TF27 | |
| PDSLHKAPKKKSIKS | 751 | O75145 | |
| LHTLTKVPKKSLKPR | 451 | Q13415 | |
| KKPFDLHIPKHKTSL | 676 | Q8NDH2 | |
| RHHGTPTSKKKTLKP | 246 | Q5H9B9 | |
| KKKKEKHTHHAPLSP | 1031 | P12259 | |
| LPKSPKRHHVDITKK | 581 | Q8N1K5 | |
| KSLLHLHKKKKPPSI | 876 | B2RTY4 | |
| TTKSLLHLHKKKKPP | 811 | Q13459 | |
| LHLHKKKKPPSISAQ | 816 | Q13459 |